세계의 3D 바이오프린팅 시장 : 부품(3D 바이오프린터, 바이오잉크, 소프트웨어, 소모품), 재료, 용도(연구, 임상) 별 예측(-2029년)

3D Bioprinting Market by Component (3D bioprinters, Bioinks, Software, Consumable), Material, Application(Research, Clinical ) - Global Forecast to 2029

US $ 4,950 ￦ 6,817,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,158,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,224,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,772,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 3D 바이오프린팅 시장 규모는 2024년 13억 달러에서 예측 기간 동안 12.7%의 연평균 복합 성장률(CAGR)을 나타내며 2029년에는 24억 달러에 달할 것으로 예상됩니다.

3D 바이오프린팅 시장은 민관 협력 연구 증가, R&D에 대한 대규모 투자, 재생의료 및 줄기세포 연구에 대한 관심 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다.

조사 범위
조사 대상년도	2022-2029년
기준년도	2023년
예측 기간	2024-2029년
단위	금액(USD)
부문	구성요소별, 재료별, 용도별, 최종사용자별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

3D 바이오 프린터 부문이 압도적인 점유율을 차지하다:

기술별로는 3D 바이오 프린터 부문이 2023년 시장을 장악했으며, 3D 바이오 프린팅 기술의 발전과 장기 이식 수요 증가가 3D 바이오 프린팅 시장을 견인하는 요인으로 작용했습니다.

연구 용도가 2023년 가장 큰 점유율을 차지할 것으로 보입니다.

연구용이 2023년 시장을 주도할 것으로 예상됩니다. 이 부문은 바이오 제약 기업들이 3D 바이오 프린팅 기술 활용을 강화하는 등의 요인으로 인해 예측 기간 동안 높은 CAGR로 성장할 것으로 예상됩니다.

아시아태평양이 더 빠른 속도로 성장할 가능성이 높습니다.

아시아태평양은 대규모 인구 기반과 중국, 인도, 동남아시아 국가들의 의료비 증가, 의료 개선을 위한 제휴 및 협력 증가로 인해 큰 성장을 보일 것으로 예상됩니다. 또한, R&D의 집약도가 높아서 이 지역에 진출한 기업들이 적극적으로 진출하고 있으며, 줄기세포 연구의 급격한 증가는 시장 성장을 더욱 촉진하고 있습니다.

세계 3D 바이오프린팅(3D Bioprinting) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 및 특허 동향, 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
• 기술 분석
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• 특허 분석
• 무역 분석
• 주요 컨퍼런스 및 이벤트
• 규제 상황
• 투자와 자금조달 시나리오
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준

제6장 3D 바이오프린팅 시장 : 컴포넌트별

• 3D 바이오프린터
  • 마이크로 압출 바이오프린터
  • 잉크젯 3D 바이오프린터
  • 레이저 어시스트 바이오프린터
  • 스테레오리소그래피 기반 바이오프린터
  • 자기 3D 바이오프린터
  • 기타
• 바이오 잉크
  • 천연 바이오 잉크
  • 하이브리드 바이오 잉크
  • 합성 바이오 잉크
• 소프트웨어
• 소모품

제7장 3D 바이오프린팅 시장 : 재료별

• 생세포
• 하이드로겔
• 세포외 매트릭스
• 기타

제8장 3D 바이오프린팅 시장 : 용도별

• 연구 용도
  • 의약품 연구
  • 재생의료
  • 3D 세포배양
• 임상 용도
  • 피부
  • 뼈 및 연골
  • 혈관
  • 기타

제9장 3D 바이오프린팅 시장 : 최종사용자별

• 학술연구기관
• 제약 기업 및 바이오테크놀러지 기업
• 병원

제10장 3D 바이오프린팅 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제11장 경쟁 구도

• 주요 전략/유력 기업
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 기업
  • BICO GROUP AB
  • 3D SYSTEMS, INC.
  • MERCK KGAA
  • ORGANOVO HOLDINGS INC.
  • COLLPLANT BIOTECHNOLOGIES LTD.
  • REGENHU
  • ASPECT BIOSYSTEMS LTD.
  • ADVANCED SOLUTIONS LIFE SCIENCES, LLC
  • CYFUSE BIOMEDICAL K.K.
  • ROKIT HEALTHCARE, INC.
  • HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.
  • FOLDINK
  • BRINTER
  • 3D BIOPRINTING SOLUTIONS
• 기타 기업
  • REGEMAT 3D, SL
  • POIETIS
  • SUNP BIOTECH
  • GESIM-GESELLSCHAFT FUR SILIZIUM-MIKROSYSTEME MBH
  • MEDPRIN
  • VOXCELL BIOINNOVATION INC.
  • PRODWAYS
  • INVENTIA LIFE SCIENCE PTY LTD.
  • UPNANO GMBH
  • UPM
  • TISSUELABS

제13장 부록

LSH

영문 목차

영문목차

The 3D bioprinting market is projected to reach USD 2.4 Billion by 2029 from USD 1.3 Billion in 2024, at a CAGR of 12.7% during the forecast period. The 3D bioprinting market is driven by several key factors, including increasing collaborations between public and private entities and significant investments in research and development and growing interest in regenerative medicine and stem cell research.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	By Component, By Material, By Application, By End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The 3D bioprinters segment held the dominant share in the 3D bioprinting market."

Based on technology, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software, and consumable. The 3D bioprinters is segmented into Microextrusion bioprinters, , inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, stereolithography-based bioprinters, and other 3D bioprinters. The 3D bioprinters segment dominated the 3D bioprinting market in 2023. Advancements in 3D bioprinting technology and rising demand for organ transplants serves as driving factor in the 3D bioprinting market.

"Research application accounted for the largest share of the application in 2023."

Based on application, the 3D bioprinting market is segmented into research application and clinical application. The research application is further segmented into regenerative medicine, 3D cell culture and drug research Also, the clinical application is segmented into bone & cartilage, blood vessels, skin and other clinical applications. In 2023, Research segment dominated the 3D bioprinting market. Research segment is anticipated to grow at significant CAGR during the forecast period of 2024-2028 owing to various factors such as biopharmaceuticals firms ramping up their utilization of 3D bioprinting technology.

"Asia Pacific region is likely to grow at a faster pace in the 3D bioprinting market."

The 3D bioprinting market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. The Asia-Pacific region is poised to experience significant growth in the 3D bioprinting market due to several key factors such as increasing healthcare expenditure in countries like China, India, and Southeast Asian nations region benefits from a significant population base and domestic system manufacturing, driving increased partnerships and collaborations aimed at healthcare improvement. With a high level of R&D intensity, market players are actively expanding their presence in the region, complemented by a surge in stem cell research, further stimulate market growth.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70%, and Demand Side - 30%
• By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East-and Africa -5%

List of Companies Profiled in the Report:

• BICO Group AB (Sweden)
• 3D Systems Inc. (US)
• Merck KGaA (Germany)
• Organovo Holdings Inc (US)
• Collplant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• Aspect Biosystem Ltd. (Canada)
• Advanced Solutions Life Sciences, llc (US)
• Cyfuse Biomedical K.K (Japan)
• Rokit Healthcare Inc (South Korea)
• Hangzhou Genofei Biotechnology Co., Ltd. (China)
• Foldink (Armenia)
• Brinter (US)
• 3D bioprinting solution (Russia).
• REGEMAT 3D, SL (Spain)
• Ροietis (France)
• Sunp Biotech (US)
• GeSim - Gesellschaft Fur Silizium-Mikrosysteme Mbh (Germany)
• Medprin (China)
• Voxcell Bioinnovation Inc. (Canada)
• Prodways (France)
• Inventia Life Science Pty Ltd (Australia)
• Upnano Gmbh (Austria)
• UPM (Finland)
• Tissuelabs (Switzerland)

Research Coverage:

This report provides a detailed picture of the vaccine market. It aims at estimating the size and future growth potential of the market across different segments such as the components, material, application, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D bioprinting market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting , increasing number of public-private partnerships, rising investments in R&D and medical devices), opportunities (Rising demand for organ transplants and growing demand for regenerative medicine and stem cell research) and challenges (biocompatibility issues and rigorous sterilization protocols and ethical concerns related to the use of 3D bioprinted products) are influencing the growth of 3D bioprinting market.
• Product Development/Innovation: Detailed insights on newly launched products of the 3D bioprinting market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the 3D bioprinting market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D bioprinting market..
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd (Israel), regenHU (Switzerland), Aspect Biosystem (Canada), Advanced Solutions Life Sciences, llc (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US) and 3D bioprinting solution (Russia).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS COVERED
  • FIGURE 1 3D BIOPRINTING MARKET: SEGMENTS COVERED
  • 1.3.2 REGIONS COVERED
  • FIGURE 2 3D BIOPRINTING MARKET: REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 RESEARCH LIMITATIONS
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
  • 1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 3 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Breakdown of primaries
  • FIGURE 4 BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 5 3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023
  • FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023)
  • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES
  • 2.2.2 MARKET SIZE ESTIMATION, BY SEGMENT
  • FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS
  • 2.3.1 CAGR PROJECTIONS
  • FIGURE 10 3D BIOPRINTING MARKET: CAGR PROJECTIONS, 2024-2029
  • 2.3.2 IMPACT OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• 2.4 STUDY ASSUMPTIONS
• 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
• 2.6 RISK ANALYSIS
• 2.7 IMPACT OF ECONOMIC RECESSION ON 3D BIOPRINTING MARKET

3 EXECUTIVE SUMMARY

• FIGURE 12 3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION)
• FIGURE 13 3D BIOPRINTING MARKET, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 3D BIOPRINTING MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 3D BIOPRINTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET

4 PREMIUM INSIGHTS

• 4.1 3D BIOPRINTING MARKET OVERVIEW
  • FIGURE 17 RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET
• 4.2 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2023)
  • FIGURE 18 US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• 4.3 3D BIOPRINTING MARKET, BY COMPONENT, 2024 VS. 2029
  • FIGURE 19 3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD
• 4.4 3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 21 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries
    • 5.2.1.2 Technological advancements in 3D bioprinting
    • 5.2.1.3 Increasing number of public-private partnerships
    • 5.2.1.4 Rising investments in medical device R&D
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Risk of 3D bioprinting failures
    • 5.2.2.2 High cost of 3D bioprinters and bioinks
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising demand for organ transplants
  • FIGURE 22 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
    • 5.2.3.2 Growing demand for regenerative medicine and stem cell research
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Biocompatibility issues and rigorous sterilization protocols
    • 5.2.4.2 Ethical concerns related to use of 3D-bioprinted products
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 23 REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Extrusion-based bioprinting
    • 5.4.1.2 Inkjet-based bioprinting
    • 5.4.1.3 Stereolithography bioprinting
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Microfluidics and microfabrication
    • 5.4.2.2 Nanotechnology and nanomaterials
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 3D scanning and imaging
    • 5.4.3.2 Organ-on-a-chip
    • 5.4.3.3 Organoids technology
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE OF COMPONENTS, BY REGION
  • TABLE 2 3D BIOPRINTING MARKET: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021-2023
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 24 3D BIOPRINTING MARKET: VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
  • FIGURE 25 3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS
  • TABLE 3 3D BIOPRINTING MARKET: ROLE IN SUPPLY CHAIN
• 5.8 ECOSYSTEM ANALYSIS
  • FIGURE 26 3D BIOPRINTING MARKET: ECOSYSTEM MAP
  • 5.8.1 3D BIOPRINTER VENDORS
  • TABLE 4 3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM
  • 5.8.2 BIOINK VENDORS
  • TABLE 5 BIOINK VENDORS: ROLE IN ECOSYSTEM
  • 5.8.3 END USERS
  • TABLE 6 END USERS: ROLE IN ECOSYSTEM
  • 5.8.4 REGULATORY BODIES
  • TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
• 5.9 PATENT ANALYSIS
  • 5.9.1 METHODOLOGY
  • 5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014-2024
  • 5.9.3 INNOVATION AND PATENT APPLICATION
  • FIGURE 27 NUMBER OF PATENTS GRANTED ANNUALLY, 2014-2024
  • 5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
  • FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
  • FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014-2024
  • TABLE 9 3D BIOPRINTING MARKET: TOP 12 PATENT OWNERS IN US, 2014-2024
  • TABLE 10 PATENTS IN 3D BIOPRINTING MARKET, 2023
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
  • TABLE 11 IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019-2023 (TONS)
  • 5.10.2 EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
  • TABLE 12 EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019-2023 (TONS)
  • 5.10.3 IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
  • TABLE 13 IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019-2023 (USD)
  • 5.10.4 EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
  • TABLE 14 EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019-2023 (USD)
• 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 15 3D BIOPRINTING MARKET: KEY CONFERENCES AND EVENTS
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 CDRH REGULATIONS ON 3D BIOPRINTING
  • 5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 INVESTMENT AND FUNDING SCENARIO
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 3D BIOPRINTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 20 3D BIOPRINTING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF BUYERS
  • 5.14.4 BARGAINING POWER OF SUPPLIERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • 5.15.2 KEY BUYING CRITERIA
    • 5.15.2.1 Key buying criteria for top three end users
  • TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET

6 3D BIOPRINTING MARKET, BY COMPONENT

• 6.1 INTRODUCTION
  • TABLE 23 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• 6.2 3D BIOPRINTERS
  • TABLE 24 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 25 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 MICRO EXTRUSION BIOPRINTERS
    • 6.2.1.1 Adaptability to different biomaterial types to fuel segment growth
  • TABLE 32 MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 INKJET 3D BIOPRINTERS
    • 6.2.2.1 High cell viability and low cost to propel market growth
  • TABLE 39 INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 LASER-ASSISTED BIOPRINTERS
    • 6.2.3.1 Higher resolution and better formation of 3D structures to augment segment growth
  • TABLE 46 LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.4 STEREOLITHOGRAPHY-BASED BIOPRINTERS
    • 6.2.4.1 Better printing quality, speed, and cell viability to aid growth
  • TABLE 53 STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.5 MAGNETIC 3D BIOPRINTERS
    • 6.2.5.1 Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth
  • TABLE 60 MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.6 OTHER 3D BIOPRINTERS
  • TABLE 67 OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 BIOINKS
  • TABLE 74 3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 3D BIOPRINTING MARKET FOR BIOINKS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 NATURAL BIOINKS
    • 6.3.1.1 Increasing investment in R&D and product developments to drive market
  • TABLE 82 NATURAL BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2 HYBRID BIOINKS
    • 6.3.2.1 Higher mechanical strength and greater biocompatibility to boost segment growth
  • TABLE 89 HYBRID BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3 SYNTHETIC BIOINKS
    • 6.3.3.1 Flexibility, control, and consistency to aid segment growth
  • TABLE 96 SYNTHETIC BIOINKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.4 SOFTWARE
  • 6.4.1 INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH
  • TABLE 103 3D BIOPRINTING MARKET FOR SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 EUROPE: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 LATIN AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 MIDDLE EAST: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.5 CONSUMABLES
  • 6.5.1 NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET
  • TABLE 110 3D BIOPRINTING MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 EUROPE: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)

7 3D BIOPRINTING MARKET, BY MATERIAL

• 7.1 INTRODUCTION
  • TABLE 117 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
• 7.2 LIVING CELLS
  • 7.2.1 INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH
  • TABLE 118 3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 MIDDLE EAST: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 HYDROGELS
  • 7.3.1 INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH
  • TABLE 125 3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 EXTRACELLULAR MATRICES
  • 7.4.1 INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH
  • TABLE 132 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 LATIN AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 MIDDLE EAST: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.5 OTHER MATERIALS
  • TABLE 139 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 EUROPE: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 MIDDLE EAST: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022-2029 (USD MILLION)

8 3D BIOPRINTING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 146 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 8.2 RESEARCH APPLICATIONS
  • TABLE 147 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 149 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.1 DRUG RESEARCH
    • 8.2.1.1 Better precision and greater customization facilities in pharmaceutical sector to drive segment
  • TABLE 155 DRUG RESEARCH MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.2 REGENERATIVE MEDICINE
    • 8.2.2.1 Growing demand for organ transplants to support segment growth
  • TABLE 162 REGENERATIVE MEDICINE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.2.3 3D CELL CULTURE
    • 8.2.3.1 Rising investments in cell culture development to augment segment growth
  • TABLE 169 3D CELL CULTURE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 CLINICAL APPLICATIONS
  • TABLE 176 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.1 SKIN
    • 8.3.1.1 Rising applications in skincare and cosmetics to propel segment growth
  • TABLE 184 SKIN MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 185 NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 EUROPE: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 189 MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.2 BONE & CARTILAGE
    • 8.3.2.1 Increasing incidence of musculoskeletal conditions to support segment growth
  • TABLE 191 BONE & CARTILAGE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 193 EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.3 BLOOD VESSELS
    • 8.3.3.1 Growing focus on research activities to aid segment growth
  • TABLE 198 BLOOD VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 199 NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 200 EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3.4 OTHER CLINICAL APPLICATIONS
  • TABLE 205 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 206 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 207 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

9 3D BIOPRINTING MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 212 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.2 ACADEMIC & RESEARCH INSTITUTES
  • 9.2.1 RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
  • TABLE 213 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 EUROPE: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 219 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
  • TABLE 220 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 EUROPE: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 9.4 HOSPITALS
  • 9.4.1 RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH
  • TABLE 227 3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 228 NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 232 MIDDLE EAST: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022-2029 (USD MILLION)

10 3D BIOPRINTING MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 234 3D BIOPRINTING MARKET, BY REGION, 2022-2029 (USD MILLION)
• 10.2 NORTH AMERICA
  • FIGURE 31 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
  • TABLE 235 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 237 NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 240 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2.1 NORTH AMERICA: RECESSION IMPACT
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American 3D bioprinting market during forecast period
  • TABLE 244 US: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 245 US: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 US: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 247 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 248 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 249 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 250 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 US: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2.3 CANADA
    • 10.2.3.1 Increased number of public-private partnerships for life science research to drive market
  • TABLE 252 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 253 CANADA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 CANADA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 256 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 257 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 10.3 EUROPE
  • TABLE 260 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 261 EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 262 EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 265 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 266 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.1 EUROPE: RECESSION IMPACT
  • 10.3.2 GERMANY
    • 10.3.2.1 Rising healthcare expenditure and increasing demand for organ transplants to favor market growth
  • TABLE 269 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 270 GERMANY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 GERMANY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 273 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 274 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.3 UK
    • 10.3.3.1 Rising prevalence of chronic diseases and increasing R&D activities to drive market
  • TABLE 277 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 278 UK: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 UK: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 281 UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 282 UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 UK: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.4 FRANCE
    • 10.3.4.1 Increasing availability of advanced medical technologies to support market growth
  • TABLE 285 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 286 FRANCE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 287 FRANCE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 289 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 290 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.5 ITALY
    • 10.3.5.1 Increased research investment and funding to support market growth
  • TABLE 293 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 294 ITALY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 ITALY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 297 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 298 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 300 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.6 SPAIN
    • 10.3.6.1 Favorable investment scenario and increase in number of research centers to aid market growth
  • TABLE 301 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 302 SPAIN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 303 SPAIN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 305 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 306 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3.7 REST OF EUROPE
  • TABLE 309 REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 310 REST OF EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 311 REST OF EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 REST OF EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 313 REST OF EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 314 REST OF EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 316 REST OF EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 10.4 ASIA PACIFIC
  • FIGURE 32 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
  • TABLE 317 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 319 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 321 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 322 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 323 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.1 CHINA
    • 10.4.1.1 Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth
  • TABLE 326 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 327 CHINA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 CHINA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 330 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 331 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 332 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 333 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.2 JAPAN
    • 10.4.2.1 Advancements in healthcare infrastructure to support market growth
  • TABLE 334 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 335 JAPAN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 JAPAN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 338 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 339 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 340 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.3 INDIA
    • 10.4.3.1 Increasing developments in biopharmaceutical industry to propel market growth
  • TABLE 342 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 343 INDIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 INDIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 346 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 347 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 348 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.4 AUSTRALIA
    • 10.4.4.1 Rising private and public funding for research activities to drive market
  • TABLE 350 AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 351 AUSTRALIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 AUSTRALIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 353 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 354 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 355 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.5 SOUTH KOREA
    • 10.4.5.1 Favorable government policies and high investments from private sector to fuel market growth
  • TABLE 358 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 359 SOUTH KOREA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 SOUTH KOREA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 361 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 362 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 363 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 365 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4.6 REST OF ASIA PACIFIC
  • 10.4.7 ASIA PACIFIC: RECESSION IMPACT
  • TABLE 366 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 368 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 369 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 370 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 371 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 372 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 373 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 10.5 LATIN AMERICA
  • TABLE 374 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 375 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 376 LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 377 LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 378 LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 379 LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 380 LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 381 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 382 LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.1 LATIN AMERICA: RECESSION IMPACT
  • 10.5.2 BRAZIL
    • 10.5.2.1 Brazil to hold largest share in Latin American market
  • TABLE 383 BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 384 BRAZIL: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 385 BRAZIL: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 386 BRAZIL: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 387 BRAZIL: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 388 BRAZIL: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 389 BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 390 BRAZIL: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth
  • TABLE 391 MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 392 MEXICO: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 393 MEXICO: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 394 MEXICO: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 395 MEXICO: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 396 MEXICO: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 397 MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 MEXICO: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5.4 REST OF LATIN AMERICA
  • TABLE 399 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 400 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 401 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 402 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 403 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 404 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 405 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 406 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 10.6 MIDDLE EAST
  • TABLE 407 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 408 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 409 MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 410 MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 411 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 412 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 413 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 415 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6.1 MIDDLE EAST: RECESSION IMPACT
  • 10.6.2 GCC COUNTRIES
  • TABLE 416 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 417 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 418 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 419 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 420 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 421 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 423 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 424 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2.1 Saudi Arabia
      • 10.6.2.1.1 Increasing government investments in healthcare and growing pharmaceuticals industry to support market growth
  • TABLE 425 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 426 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 427 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 428 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 429 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 430 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 431 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 432 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2.2 United Arab Emirates
      • 10.6.2.2.1 Increased R&D expenditure and advanced healthcare infrastructure to boost market growth
  • TABLE 433 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 434 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 435 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 436 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 437 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 438 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 439 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 440 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2.3 Rest of GCC countries
  • TABLE 441 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 442 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 443 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 444 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 445 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 446 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 447 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 448 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6.3 REST OF MIDDLE EAST
  • TABLE 449 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 450 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 451 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 452 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 453 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 454 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 455 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 456 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
• 10.7 AFRICA
  • 10.7.1 GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
  • TABLE 457 AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 458 AFRICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 459 AFRICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 460 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022-2029 (USD MILLION)
  • TABLE 461 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 462 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 463 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 464 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.7.2 AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY STRATEGIES/RIGHT TO WIN
  • FIGURE 33 3D BIOPRINTING MARKET: STRATEGIES ADOPTED
• 11.3 REVENUE ANALYSIS
  • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2021-2023)
• 11.4 MARKET SHARE ANALYSIS
  • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • TABLE 465 3D BIOPRINTING MARKET: DEGREE OF COMPETITION
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • FIGURE 36 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Overall footprint
  • FIGURE 37 3D BIOPRINTING MARKET: OVERALL FOOTPRINT
    • 11.5.5.2 Component footprint
  • TABLE 466 3D BIOPRINTING MARKET: COMPONENT FOOTPRINT
    • 11.5.5.3 Regional footprint
  • TABLE 467 3D BIOPRINTING MARKET: REGIONAL FOOTPRINT
    • 11.5.5.4 Material footprint
  • TABLE 468 3D BIOPRINTING MARKET: MATERIAL FOOTPRINT
    • 11.5.5.5 Application footprint
  • TABLE 469 3D BIOPRINTING MARKET: APPLICATION FOOTPRINT
• 11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • FIGURE 38 3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • 11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
  • TABLE 470 3D BIOPRINTING MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 471 3D BIOPRINTING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
• 11.7 VALUATION AND FINANCIAL METRICS
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• 11.8 BRAND/PRODUCT COMPARISON
  • FIGURE 41 3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON
  • 11.8.1 BICO GROUP AB
  • 11.8.2 REGENHU
  • 11.8.3 ROKIT HEALTHCARE, INC.
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • TABLE 472 3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2024
  • 11.9.2 DEALS
  • TABLE 473 3D BIOPRINTING MARKET: DEALS, JANUARY 2021-MARCH 2024
  • 11.9.3 EXPANSIONS
  • TABLE 474 3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021-MARCH 2024
  • 11.9.4 OTHER DEVELOPMENTS
  • TABLE 475 3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2024

12 COMPANY PROFILES

• (Business overview, Products/Solutions/Services offered, Recent developments & MnM View)**
• 12.1 KEY PLAYERS
  • 12.1.1 BICO GROUP AB
  • TABLE 476 BICO GROUP AB: COMPANY OVERVIEW
  • FIGURE 42 BICO GROUP AB: COMPANY SNAPSHOT (2023)
  • TABLE 477 BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 478 BICO GROUP AB: PRODUCT LAUNCHES
  • TABLE 479 BICO GROUP AB: DEALS
  • TABLE 480 BICO GROUP AB: EXPANSIONS
  • TABLE 481 BICO GROUP AB: OTHER DEVELOPMENTS
  • 12.1.2 3D SYSTEMS, INC.
  • TABLE 482 3D SYSTEMS, INC.: COMPANY OVERVIEW
  • FIGURE 43 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
  • TABLE 483 3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 484 3D SYSTEMS, INC.: DEALS
  • TABLE 485 3D SYSTEMS, INC.: EXPANSIONS
  • 12.1.3 MERCK KGAA
  • TABLE 486 MERCK KGAA: COMPANY OVERVIEW
  • FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • TABLE 487 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 488 MERCK KGAA: EXPANSIONS
  • 12.1.4 ORGANOVO HOLDINGS INC.
  • TABLE 489 ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW
  • FIGURE 45 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023)
  • TABLE 490 ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 491 ORGANOVO HOLDINGS INC.: DEALS
  • 12.1.5 COLLPLANT BIOTECHNOLOGIES LTD.
  • TABLE 492 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
  • FIGURE 46 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)
  • TABLE 493 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 494 COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 495 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES
  • TABLE 496 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS
  • 12.1.6 REGENHU
  • TABLE 497 REGENHU: COMPANY OVERVIEW
  • TABLE 498 REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 12.1.7 ASPECT BIOSYSTEMS LTD.
  • TABLE 499 ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW
  • TABLE 500 ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 501 ASPECT BIOSYSTEMS LTD.: DEALS
  • 12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC
  • TABLE 502 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW
  • TABLE 503 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 504 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS
  • TABLE 505 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS
  • 12.1.9 CYFUSE BIOMEDICAL K.K.
  • TABLE 506 CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW
  • TABLE 507 CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 12.1.10 ROKIT HEALTHCARE, INC.
  • TABLE 508 ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW
  • TABLE 509 ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 12.1.11 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.
  • TABLE 510 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 511 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 12.1.12 FOLDINK
  • TABLE 512 FOLDINK: COMPANY OVERVIEW
  • TABLE 513 FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • 12.1.13 BRINTER
  • TABLE 514 BRINTER: COMPANY OVERVIEW
  • TABLE 515 BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 516 BRINTER: DEALS
  • TABLE 517 BRINTER: EXPANSIONS
  • 12.1.14 3D BIOPRINTING SOLUTIONS
  • TABLE 518 3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW
  • TABLE 519 3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
• *Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
• 12.2 OTHER PLAYERS
  • 12.2.1 REGEMAT 3D, SL
  • TABLE 520 REGEMAT 3D, SL: COMPANY OVERVIEW
  • 12.2.2 POIETIS
  • TABLE 521 POIETIS: COMPANY OVERVIEW
  • 12.2.3 SUNP BIOTECH
  • TABLE 522 SUNP BIOTECH: COMPANY OVERVIEW
  • 12.2.4 GESIM-GESELLSCHAFT FUR SILIZIUM-MIKROSYSTEME MBH
  • TABLE 523 GESIM-GESELLSCHAFT FUR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW
  • 12.2.5 MEDPRIN
  • TABLE 524 MEDPRIN: COMPANY OVERVIEW
  • 12.2.6 VOXCELL BIOINNOVATION INC.
  • TABLE 525 VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW
  • 12.2.7 PRODWAYS
  • TABLE 526 PRODWAYS: COMPANY OVERVIEW
  • 12.2.8 INVENTIA LIFE SCIENCE PTY LTD.
  • TABLE 527 INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW
  • 12.2.9 UPNANO GMBH
  • TABLE 528 UPNANO GMBH: COMPANY OVERVIEW
  • 12.2.10 UPM
  • TABLE 529 UPM: COMPANY OVERVIEW
  • 12.2.11 TISSUELABS
  • TABLE 530 TISSUELABS: COMPANY OVERVIEW

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료